Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study

Mouna Stayoussef, Azza Habel, Weili Xu, Mariem Bessaad, Hanen Bouaziz, Mouna Ayadi, Wassim Y Almawi, Anis Larbi · 2026

Read Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study by Mouna Stayoussef, Azza Habel, Weili Xu, Mariem Bessaad, Hanen Bouaziz, Mouna Ayadi, Wassim Y Almawi, Anis Larbi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0348953.txt.

Description

Mouna Stayoussef and colleagues searched the blood of breast cancer patients for immune checkpoint proteins that could flag the disease early. These proteins are the brakes and accelerators of anti-tumor immunity, and some float freely in serum. Using a multiplex test that reads sixteen at once, they compared eighty-eight untreated patients with forty-nine healthy controls.

Seven proteins differed clearly between the groups, and together they identified cancer with accuracy beating the two standard blood markers, while a distinct eight-protein pattern marked the aggressive triple-negative subtype. The panel also related to chemotherapy response and early progression. A blood test that both detects breast cancer and sorts its hardest subtype could spare patients invasive steps and speed treatment choices.

Catalog record

CREATORMouna Stayoussef, Azza Habel, Weili Xu, Mariem Bessaad, Hanen Bouaziz, Mouna Ayadi, Wassim Y Almawi, Anis Larbi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42206
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0348953

Browse the full library · About the Tower of Babel